Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (Q48459029)
Jump to navigation
Jump to search
scientific article published in August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. |
scientific article published in August 2006 |
Statements
1 reference
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (English)
1 reference
Bassem I Razzouk
1 reference
Jeffrey D Hord
1 reference
Marilyn Hockenberry
1 reference
Denise Williams
1 reference
Wayne R Rackoff
1 reference
1 August 2006
1 reference
1 reference
24
1 reference
22
1 reference
3583-3589
1 reference
Identifiers
1 reference
1 reference